718 results on '"Scattoni, V"'
Search Results
2. Prostate volume is associated with optimal “trifecta” outcomes after holep – results from a prospective trial (EXPHO)
3. Unfavourable outcomes after holmium laser enucleation of the prostate (HoLEP) are common also in the hands of a very esperienced surgeon – results from a prospective trial (ExpHo)
4. What results should you expect from holmium laser enucleation of the prostate after completing the surgeon’s learning curve? benchmark results from an experienced single surgeon series of patients with large prostate
5. Preoperative characteristics and surgical outcomes in patients submitted to holmium laser enucleation of the prostate (HoLEP) ten years ago vs. a contemporary cohort: a real-life analysis
6. Preoperative frailty status is a predictor of 90-days readmission in radical cystectomy candidates
7. Does prostate volume affect early continence recovery after holmium laser enucleation of the prostate? – Results from a prospective trial (ExpHo)
8. Limited vs extended lymph node dissection in T1G3 bladder cancer patients treated with radical cystectomy: is this group responsible for the negative results of the LEA trial?
9. Incongruence between turb and radical cystectomy findings in terms of histological variant identification: analysis of all potential clinical risk factors
10. Definition of a structured training curriculum for holmium laser enucleation of the prostate
11. Incongruence between TURB and radical cystectomy findings in terms of histological variant identification: Analysis of all potential clinical risk factors
12. Diagnosis of local recurrence after radical prostatectomy
13. Diagnosis of local recurrence after radical prostatectomy
14. SC70 - Prostate volume is associated with optimal “trifecta” outcomes after holep – results from a prospective trial (EXPHO)
15. SC69 - Risk of orgasmic function impairment after HoLEP – findings of a prospective real-life trial (EXPHO)
16. Radical nephrocapsulectomy in ECC and deep hypothermic arrested circulation in RCC with thrombosis of the inferior V. cava-atrium DX: surgical technique and personal series
17. Postoperative complications after holmium laser enucleation of the prostate in a high volume center with more than 15 years of experience
18. Which cancers are still diagnosed by standard prostate biopsy without an upfront multiparametric MRI? Results from a tertiary care, high volume centre
19. A0874 - Prostate volume is associated with optimal TRIFECTA outcomes after HoLEP – results from a prospective trial (ExpHo)
20. A0543 - Risk of orgasmic function impairment after HoLEP – findings of a prospective real-life trial (ExpHo)
21. SC168 - Preoperative frailty status is a predictor of 90-days readmission in radical cystectomy candidates
22. SC112 - Preoperative characteristics and surgical outcomes in patients submitted to holmium laser enucleation of the prostate (HoLEP) ten years ago vs. a contemporary cohort: a real-life analysis
23. SC111 - Does prostate volume affect early continence recovery after holmium laser enucleation of the prostate? – Results from a prospective trial (ExpHo)
24. SC110 - Unfavourable outcomes after holmium laser enucleation of the prostate (HoLEP) are common also in the hands of a very esperienced surgeon – results from a prospective trial (ExpHo)
25. SC109 - What results should you expect from holmium laser enucleation of the prostate after completing the surgeon’s learning curve? benchmark results from an experienced single surgeon series of patients with large prostate
26. P0070 - Does prostate volume affect early continence recovery after holmium laser enucleation of the prostate? Results from a prospective trial (ExpHo)
27. P0071 - Unfavourable outcomes after Holmium Laser Enucleation of the Prostate (HoLEP) are common also in the hands of a very esperienced surgeon – Results from a prospective trial (ExpHo)
28. Clinical comparison of holmium laser enucleation of the prostate (HoLEP) and bipolar transurethral enucleation of the prostate (BTUEP) in patients under either anticoagulation or antiplatelet therapy
29. Which cancers are still diagnosed by standard prostate biopsy without an upfront multiparametric MRI? Results from a tertiary care, high volume centre
30. Development and external validation of a novel model to indentify patients who can avoid systematic prostate biopsy in addition to mp-MRI targeted biopsies: Results from a two-center series
31. Which patients with clinically node prostate cancer benefit from radical prostatectomy? The impact of the size and site of nodal involvement on long-term outcomes
32. Central prostate biopsy revision at referral center is key for correct patient management: Results from a prospective, single center series
33. SC307 - Limited vs extended lymph node dissection in T1G3 bladder cancer patients treated with radical cystectomy: is this group responsible for the negative results of the LEA trial?
34. SC296 - Incongruence between turb and radical cystectomy findings in terms of histological variant identification: analysis of all potential clinical risk factors
35. Prevalence and prognostic impact of prostate cancer histological variants at radical prostatectomy: A long-term, single center analysis
36. Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy
37. Diagnosis of high-grade prostatic intraepithelial neoplasia: the impact of the number of biopsy cores at initial sampling on cancer detection after a saturation re-biopsy
38. The Number Of Cores Taken Is A Major Predictor Of Insignificant Prostate Cancer In Patients Diagnosed With A Single Microfocus At Initial Biopsy: Implications For The Selection Of Candidates Suitable For Active Surveillance
39. NEED FOR MORE ACCURATE BIOPSY SAMPLING: CORRELATION BETWEEN CORES TAKEN AND INSIGNIFICANT PROSTATE CANCER AT RADICAL PROSTATECTOMY
40. CHANGING AND UNCHANGING FACE OF HIGH RISK PROSTATE CANCER. RESULTS FROM A 15-YEAR, SINGLE INSTITUTION SERIES
41. Spatial distribution of positive cores improves the selection of patients with low-risk prostate cancer as candidates for active surveillance
42. NUMBER OF POSITIVE SPOTS AT PET-CT SCAN PREDICTS CANCER SPECIFIC AND OVERALL SURVIVAL IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENCE AFTER RADICAL PROSTATECTOMY
43. Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre
44. Ten systematic transrectal-guided prostate re-biopsies in patients with a negative prostatic biopsy
45. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients
46. Oncological and functional outcomes of patients eligible for active surveillance treated with radical prostatectomy
47. Misclassification of micro-focus prostate cancer decreases with the extent of biopsy sampling. Importance of accurate detection
48. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy
49. IDENTIFYING PATIENTS AT REAL RISK OF DYING FROM PROSTATE CANCER. A NOVEL RISK SCORE FOR THE SELECTION OF CANDIDATES FOR ADJUVANT RADIATION THERAPY
50. How to expand indications criteria for active surveillance without compromising cancer control. The importance of the extent of biopsy sampling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.